BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-04-09 |
|---|---|---|---|---|
| 2026 | $70.0 | $59.24 | $78.29 | 24.33% |
| 2027 | $81.46 | $77.58 | $83.49 | 44.69% |
| 2028 | $68.64 | $63.53 | $76.64 | 21.93% |
| 2029 | $68.89 | $67.23 | $70.69 | 22.35% |
| 2030 | $85.8 | $71.92 | $95.06 | 52.39% |
| 2031 | $90.96 | $86.51 | $99.12 | 61.56% |
| 2032 | $109.87 | $103.1 | $114.68 | 95.15% |
| 2033 | $122.56 | $118.61 | $125.44 | 117.69% |
| 2034 | $131.14 | $126.79 | $133.21 | 132.92% |
| 2035 | $135.5 | $133.45 | $136.93 | 140.68% |
| 2036 | $137.43 | $137.13 | $137.73 | 144.1% |
The 7 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$82.14 with a high forecast of $119.0 and a low forecast of $55.0.
The average BioMarin Pharmaceutical stock forecast represents a 45.9%
increase from the last price of $56.2999992370605.
For BioMarin Pharmaceutical stock forecast for 2026, 8 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $70.0, a high forecast of $78.29, and a low forecast of $59.24.
The average BioMarin Pharmaceutical stock forecast 2026 represents a 24.33%
increase from the last price of $56.2999992370605.
For BioMarin Pharmaceutical stock forecast for 2027, 12 predictions are offered for each month of 2027 with average BioMarin Pharmaceutical stock
forecast of $81.46, a high forecast of $83.49, and a low forecast of $77.58.
The average BioMarin Pharmaceutical stock forecast 2027 represents a 44.69%
increase from the last price of $56.2999992370605.
For BioMarin Pharmaceutical stock forecast for 2029, 12 predictions are offered for each month of 2029 with average BioMarin Pharmaceutical stock
forecast of $68.89, a high forecast of $70.69, and a low forecast of $67.23.
The average BioMarin Pharmaceutical stock forecast 2029 represents a 22.35%
increase from the last price of $56.2999992370605.
For BioMarin Pharmaceutical stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $90.96, a high forecast of $99.12, and a low forecast of $86.51.
The average BioMarin Pharmaceutical stock forecast 2031 represents a 61.56%
increase from the last price of $56.2999992370605.
For BioMarin Pharmaceutical stock forecast 2032, 12 predictions are offered for each month of 2032 with average BioMarin Pharmaceutical stock
forecast of $109.87, a high forecast of $114.68, and a low forecast of $103.1.
The average BioMarin Pharmaceutical stock forecast 2032 represents a 95.15%
increase from the last price of $56.2999992370605.
For BioMarin Pharmaceutical stock forecast for 2036 (10 year), 4 predictions are offered for each month of 2036 with average BioMarin Pharmaceutical stock
forecast of $137.43, a high forecast of $137.73, and a low forecast of $137.13.
The average BioMarin Pharmaceutical stock forecast 2036 represents a 144.1%
increase from the last price of $56.2999992370605.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $82.14, and this show a -9.74% decrease in average from the prior price target of the each prediction. Also, this average forecast of $82.14 represents a -14.31% decrease from the past average forecast of $95.86, 6 months ago from 7 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-10-28 | Truist Securities | $90.00 | $80.0000 | Buy |
| 2025-10-28 | Wells Fargo | $90.00 | $70.0000 | Overweight |
| 2025-10-28 | Stifel | $91.0000 | $73.0000 | Buy |
| 2025-10-28 | Barclays | $86.00 | $80.0000 | Overweight |
| 2025-10-28 | Morgan Stanley | $104.0000 | $98.0000 | Overweight |
| 2025-10-27 | HC Wainwright & Co. | $60.00 | $55.0000 | Neutral |
| 2025-10-09 | JP Morgan | $116.0000 | $119.0000 | Overweight |
| 2025-09-08 | HC Wainwright & Co. | $60 | Neutral | |
| 2025-08-06 | Guggenheim | $101.0000 | $106.0000 | Buy |
| 2025-08-05 | UBS | $113.00 | $114.0000 | Buy |
| 2025-07-22 | Morgan Stanley | $97.0000 | $96.0000 | Overweight |
| 2025-07-14 | JP Morgan | $108.0000 | $113.0000 | Overweight |
| 2025-05-05 | Goldman Sachs | $124.0000 | $104.0000 | Buy |
| 2025-05-02 | Citigroup | $82.00 | $78.0000 | Neutral |
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-04-13 | $58.10 | 3.19% |
| 2026-04-14 | $59.42 | 2.28% |
| 2026-04-15 | $59.76 | 0.57% |
| 2026-04-16 | $60.98 | 2.05% |
| 2026-04-17 | $60.79 | -0.32% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 May. is $59.24 , for 2027 Apr. is $83.22 , for 2030 Apr. is $79.28 , for 2031 Apr. is $89.69 , for 2035 Apr. is $134.82 , and for 2036 Apr. is $137.73.
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 May. | $59.24 | 5.22% |
| 2026 Jun. | $63.48 | 7.15% |
| 2026 Jul. | $67.02 | 5.57% |
| 2026 Aug. | $69.69 | 4.00% |
| 2026 Sep. | $71.94 | 3.22% |
| 2026 Oct. | $74.16 | 3.08% |
| 2026 Nov. | $76.16 | 2.71% |
| 2026 Dec. | $78.29 | 2.79% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $80.31 | 2.58% |
| 2027 Feb. | $81.76 | 1.81% |
| 2027 Mar. | $82.60 | 1.02% |
| 2027 Apr. | $83.22 | 0.75% |
| 2027 May. | $83.49 | 0.33% |
| 2027 Jun. | $83.41 | -0.10% |
| 2027 Jul. | $83.03 | -0.46% |
| 2027 Aug. | $82.30 | -0.87% |
| 2027 Sep. | $81.23 | -1.30% |
| 2027 Oct. | $79.95 | -1.57% |
| 2027 Nov. | $78.67 | -1.61% |
| 2027 Dec. | $77.58 | -1.38% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $76.64 | -1.20% |
| 2028 Feb. | $75.57 | -1.40% |
| 2028 Mar. | $73.90 | -2.22% |
| 2028 Apr. | $71.52 | -3.22% |
| 2028 May. | $68.56 | -4.13% |
| 2028 Jun. | $65.79 | -4.04% |
| 2028 Jul. | $64.03 | -2.68% |
| 2028 Aug. | $63.53 | -0.77% |
| 2028 Sep. | $64.05 | 0.81% |
| 2028 Oct. | $65.21 | 1.82% |
| 2028 Nov. | $66.68 | 2.25% |
| 2028 Dec. | $68.25 | 2.35% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $69.40 | 1.69% |
| 2029 Feb. | $69.91 | 0.74% |
| 2029 Mar. | $69.73 | -0.27% |
| 2029 Apr. | $69.01 | -1.02% |
| 2029 May. | $68.12 | -1.29% |
| 2029 Jun. | $67.45 | -0.99% |
| 2029 Jul. | $67.23 | -0.33% |
| 2029 Aug. | $67.61 | 0.58% |
| 2029 Sep. | $68.41 | 1.18% |
| 2029 Oct. | $69.20 | 1.16% |
| 2029 Nov. | $69.85 | 0.94% |
| 2029 Dec. | $70.69 | 1.21% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $71.92 | 1.73% |
| 2030 Feb. | $73.72 | 2.50% |
| 2030 Mar. | $76.16 | 3.31% |
| 2030 Apr. | $79.28 | 4.10% |
| 2030 May. | $82.88 | 4.55% |
| 2030 Jun. | $86.39 | 4.22% |
| 2030 Jul. | $89.36 | 3.44% |
| 2030 Aug. | $91.77 | 2.71% |
| 2030 Sep. | $93.59 | 1.98% |
| 2030 Oct. | $94.70 | 1.18% |
| 2030 Nov. | $95.06 | 0.38% |
| 2030 Dec. | $94.76 | -0.31% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $93.95 | -0.85% |
| 2031 Feb. | $92.76 | -1.27% |
| 2031 Mar. | $91.29 | -1.58% |
| 2031 Apr. | $89.69 | -1.75% |
| 2031 May. | $88.21 | -1.65% |
| 2031 Jun. | $87.06 | -1.31% |
| 2031 Jul. | $86.51 | -0.63% |
| 2031 Aug. | $87.04 | 0.62% |
| 2031 Sep. | $88.87 | 2.10% |
| 2031 Oct. | $91.74 | 3.23% |
| 2031 Nov. | $95.27 | 3.85% |
| 2031 Dec. | $99.12 | 4.04% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $103.10 | 4.02% |
| 2032 Feb. | $107.13 | 3.91% |
| 2032 Mar. | $110.89 | 3.51% |
| 2032 Apr. | $113.65 | 2.50% |
| 2032 May. | $114.68 | 0.90% |
| 2032 Jun. | $113.67 | -0.88% |
| 2032 Jul. | $111.29 | -2.10% |
| 2032 Aug. | $108.48 | -2.52% |
| 2032 Sep. | $106.45 | -1.88% |
| 2032 Oct. | $106.43 | -0.02% |
| 2032 Nov. | $109.04 | 2.45% |
| 2032 Dec. | $113.63 | 4.21% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $118.61 | 4.38% |
| 2033 Feb. | $122.23 | 3.06% |
| 2033 Mar. | $123.84 | 1.32% |
| 2033 Apr. | $124.00 | 0.12% |
| 2033 May. | $123.22 | -0.62% |
| 2033 Jun. | $122.13 | -0.89% |
| 2033 Jul. | $121.34 | -0.64% |
| 2033 Aug. | $121.25 | -0.08% |
| 2033 Sep. | $121.81 | 0.46% |
| 2033 Oct. | $122.79 | 0.81% |
| 2033 Nov. | $124.06 | 1.03% |
| 2033 Dec. | $125.44 | 1.12% |
BMRN : BioMarin Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $126.79 | 1.08% |
| 2034 Feb. | $128.00 | 0.95% |
| 2034 Mar. | $129.05 | 0.82% |
| 2034 Apr. | $129.98 | 0.72% |
| 2034 May. | $130.85 | 0.67% |
| 2034 Jun. | $131.63 | 0.60% |
| 2034 Jul. | $132.27 | 0.48% |
| 2034 Aug. | $132.72 | 0.34% |
| 2034 Sep. | $132.97 | 0.18% |
| 2034 Oct. | $133.05 | 0.06% |
| 2034 Nov. | $133.10 | 0.03% |
| 2034 Dec. | $133.21 | 0.08% |
BMRN : BioMarin Pharmaceutical stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $133.45 | 0.19% |
| 2035 Feb. | $133.85 | 0.30% |
| 2035 Mar. | $134.33 | 0.36% |
| 2035 Apr. | $134.82 | 0.36% |
| 2035 May. | $135.25 | 0.32% |
| 2035 Jun. | $135.62 | 0.27% |
| 2035 Jul. | $135.92 | 0.22% |
| 2035 Aug. | $136.17 | 0.19% |
| 2035 Sep. | $136.39 | 0.16% |
| 2035 Oct. | $136.57 | 0.13% |
| 2035 Nov. | $136.75 | 0.13% |
| 2035 Dec. | $136.93 | 0.13% |
BMRN : BioMarin Pharmaceutical stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $137.13 | 0.14% |
| 2036 Feb. | $137.33 | 0.15% |
| 2036 Mar. | $137.53 | 0.15% |
| 2036 Apr. | $137.73 | 0.14% |
Financial Data for BioMarin Pharmaceutical stock
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2026 May. is $59.2411779445187 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2027 Apr. is $83.2166049692367 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2030 Apr. is $79.2764602706591 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2031 Apr. is $89.693144994484 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2035 Apr. is $134.817794716056 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2036 Apr. is $137.726634654517
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go UP . Therefore, AIPickup would say that BioMarin Pharmaceutical (BMRN) stock is NOT overvalued.
Will BioMarin Pharmaceutical stock price go up?
Yes. The BioMarin Pharmaceutical stock price forecast for 2027 Apr. is $83.2166049692367
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2026-04-09 is $56.2999992370605 and forecast for 2027 Apr. is $83.22, BioMarin Pharmaceutical stock is a good 1 year investment.
14 Days Historical Data for BioMarin Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BMRN stock price for 2026-03-20 | $54.13 | $54.86 | $53.76 | $55.71 |
| BMRN stock price for 2026-03-23 | $54.78 | $54.87 | $54.42 | $55.34 |
| BMRN stock price for 2026-03-24 | $54.09 | $54.36 | $53.36 | $54.37 |
| BMRN stock price for 2026-03-25 | $55.59 | $54.61 | $54.61 | $55.73 |
| BMRN stock price for 2026-03-26 | $55.55 | $55.36 | $55.20 | $56.06 |
| BMRN stock price for 2026-03-27 | $54.14 | $55.55 | $54.10 | $55.60 |
| BMRN stock price for 2026-03-30 | $54.79 | $54.42 | $53.94 | $55.00 |
| BMRN stock price for 2026-03-31 | $56.49 | $54.91 | $54.91 | $56.59 |
| BMRN stock price for 2026-04-01 | $57.24 | $56.72 | $56.28 | $57.50 |
| BMRN stock price for 2026-04-02 | $55.50 | $56.42 | $54.54 | $56.55 |
| BMRN stock price for 2026-04-06 | $56.21 | $55.50 | $55.44 | $56.55 |
| BMRN stock price for 2026-04-07 | $56.22 | $56.14 | $55.36 | $56.41 |
| BMRN stock price for 2026-04-08 | $57.20 | $57.23 | $56.00 | $57.76 |
| BMRN stock price for 2026-04-09 | $56.30 | $56.57 | $55.81 | $57.09 |